Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Olfaction Disorders × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3803 Neoplasms 2952 Prostatic Neoplasms 1732 Colorectal Neoplasms 1412 Lung Neoplasms 1301 Motor Activity 789 Head and Neck Neoplasms 674 Pancreatic Neoplasms 654 Colonic Neoplasms 649 Uterine Cervical Neoplasms 635 Carcinoma, Hepatocellular 621 Carcinoma, Non-Small-Cell Lung 620 Rectal Neoplasms 565 Stomach Neoplasms 531 Brain Neoplasms 475 Ovarian Neoplasms 432 Pain 412 Anxiety Disorders 412 Neoplasm Metastasis 383 Esophageal Neoplasms 379 Polycystic Ovary Syndrome 370 Precursor Cell Lymphoblastic Leukemia-Lymphoma 352 Urinary Bladder Neoplasms 349 Fatigue 332 Melanoma 319 Multiple Myeloma 317 Lymphoma 305 Depression 300 Endometrial Neoplasms 285 Liver Neoplasms 278

Interventions

Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529332 2018-08-21

Omega-3 Supplementation for Smell Dysfunction

Stanford University

Phase NA Completed

Olfaction Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡